美 연구팀 “코로나19 걸린 사람 면역 수년간 유지될 수 있어” A new study shows people who have contracted and recovered from COVID-19 could remain immune for years. According to scientists at a medical institute in California,… participants who had COVID-19…
Scientists take the part of the virus’s genetic code which builds the distinctive ‘spike protein’ on its surface.. These genetic instructions are placed in a fat droplet, which is injected into the patient.. Patient’s immune cells make the spike protein,…
A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films: Further content: Find The Economist’s…
Moderna’s vaccine, created with the National Institutes of Health, is being studied in 30,000 volunteers who received either the real vaccination or a dummy shot For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna…
Pfizer vaccine’s success is great news – but don’t expect life to ‘return to normal by spring’ LIKE || SHARE || SUBSCRIBE Following the news that Pfizer’s vaccine for Covid-19 is showing signs of 90% efficacy, there has been a…
A COVID-19 vaccine from biotech company Moderna is also showing promise, so when might it be available? Hospital capacity is a concern across the country, but Manitoba has been hit the hardest so far. Plus, a conversation with the Canadian…
